• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染的宿主决定因素及其临床结局。

Host determinants of Helicobacter pylori infection and its clinical outcome.

作者信息

Nguyen T N, Barkun A N, Fallone C A

机构信息

Division of Gastroenterology, McGill University, Montreal, Quebec, Canada.

出版信息

Helicobacter. 1999 Sep;4(3):185-97. doi: 10.1046/j.1523-5378.1999.99294.x.

DOI:10.1046/j.1523-5378.1999.99294.x
PMID:10469193
Abstract

Greater than one-half of the world's population harbors Helicobacter pylori. The majority of infected individuals, however, remain asymptomatic, with only 10% to 20% developing diseases, including peptic ulcer disease, gastric cancer, and gastric mucosa-associated lymphoid tissue lymphoma. This article reviews host factors that may predispose an individual to both the acquisition of H. pylori infection and subsequent clinical outcome. Individuals with specific blood group antigens and human leukocyte antigen genotypes may be more susceptible to H. pylori infection. Additional factors, such as the age of acquisition, the host immune response, the site of infection, acid secretion, and interactions with nonhost factors (including bacterial virulence factors and environmental influences) may play a role in determining clinical outcome. Further investigation is required to clarify the mechanisms by which these interactions occur and, more critically, to determine their relative importance. This knowledge will enable the identification of individuals at risk of developing clinical disease with H. pylori infection.

摘要

全球超过一半的人口感染幽门螺杆菌。然而,大多数感染者并无症状,只有10%至20%的人会患上包括消化性溃疡病、胃癌和胃黏膜相关淋巴组织淋巴瘤在内的疾病。本文综述了可能使个体易感染幽门螺杆菌并影响后续临床结局的宿主因素。具有特定血型抗原和人类白细胞抗原基因型的个体可能更容易感染幽门螺杆菌。其他因素,如感染年龄、宿主免疫反应、感染部位、胃酸分泌以及与非宿主因素的相互作用(包括细菌毒力因子和环境影响),可能在决定临床结局中发挥作用。需要进一步研究以阐明这些相互作用发生的机制,更关键的是,确定它们的相对重要性。这些知识将有助于识别感染幽门螺杆菌后有临床疾病风险的个体。

相似文献

1
Host determinants of Helicobacter pylori infection and its clinical outcome.幽门螺杆菌感染的宿主决定因素及其临床结局。
Helicobacter. 1999 Sep;4(3):185-97. doi: 10.1046/j.1523-5378.1999.99294.x.
2
Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.182例消化性溃疡、黏膜相关淋巴组织型胃淋巴瘤或非溃疡性消化不良患者中8种幽门螺杆菌抗原的血清阳性率。来自欧洲和非洲的消化性溃疡患者对细胞毒素相关蛋白A(CagA)和35 kDa抗原的血清反应率更高。
Eur J Gastroenterol Hepatol. 1999 Jul;11(7):721-6. doi: 10.1097/00042737-199907000-00007.
3
Helicobacter pylori, T cells and cytokines: the "dangerous liaisons".幽门螺杆菌、T细胞与细胞因子:“危险的关联”
FEMS Immunol Med Microbiol. 2005 May 1;44(2):113-9. doi: 10.1016/j.femsim.2004.10.013.
4
Impact of Helicobacter pylori Virulence Factors on the Host Immune Response and Gastric Pathology.幽门螺杆菌毒力因子对宿主免疫反应和胃病理的影响。
Curr Top Microbiol Immunol. 2019;421:21-52. doi: 10.1007/978-3-030-15138-6_2.
5
A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection.幽门螺杆菌感染临床结局潜在细菌决定因素的综述。
Can J Microbiol. 1998 Mar;44(3):201-10.
6
Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma.慢性胃炎、消化性溃疡、胃癌及低度黏膜相关淋巴组织(MALT)淋巴瘤患者胃水平的幽门螺杆菌抗原特异性T细胞反应。
Microbes Infect. 2003 Jul;5(8):723-30. doi: 10.1016/s1286-4579(03)00114-x.
7
What are the host factors that place an individual at risk for Helicobacter pylori-associated disease?
Gastroenterology. 1997 Dec;113(6 Suppl):S15-20. doi: 10.1016/s0016-5085(97)80005-4.
8
[Helicobacter pylori and gastric cancer].[幽门螺杆菌与胃癌]
Rev Gastroenterol Peru. 2008 Jul-Sep;28(3):258-66.
9
Helicobacter pylori: perspectives and time trends.幽门螺杆菌:展望与时间趋势。
Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):628-38. doi: 10.1038/nrgastro.2014.99. Epub 2014 Jul 8.
10
Helicobacter pylori infection and gastric MALT lymphoma.幽门螺杆菌感染与胃黏膜相关淋巴组织淋巴瘤
Rocz Akad Med Bialymst. 2005;50:54-61.

引用本文的文献

1
How did the ancient bacterium, , cause an epidemic of chronic duodenal ulceration?这种古老的细菌是如何引发慢性十二指肠溃疡流行的呢? 需注意,你提供的原文中“,”处内容缺失,以上译文是基于完整句子结构推测补全后的翻译。
JGH Open. 2021 May 18;5(6):636-642. doi: 10.1002/jgh3.12560. eCollection 2021 Jun.
2
Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.将驱虫药尼氯硝唑重新用于对抗幽门螺杆菌。
Sci Rep. 2018 Feb 27;8(1):3701. doi: 10.1038/s41598-018-22037-x.
3
Helicobacter pylori eradication: gastric cancer prevention.幽门螺杆菌根除:预防胃癌
BMJ Clin Evid. 2015 Dec 1;2015:0406.
4
Searching for Helicobacter pylori and Chlamydia pneumoniae in primary endodontic infections.在原发性牙髓感染中检测幽门螺杆菌和肺炎衣原体
Eur J Dent. 2012 Apr;6(2):158-62.
5
Helicobacter pylori infection.幽门螺杆菌感染
BMJ Clin Evid. 2009 Oct 1;2009:0406.
6
Prevalence of horB gene among the Helicobacter pylori strains isolated from dyspeptic patients: first report from Iran.消化不良患者分离的幽门螺杆菌菌株中 horB 基因的流行情况:来自伊朗的首次报告。
Intern Emerg Med. 2012 Dec;7(6):505-8. doi: 10.1007/s11739-011-0614-7. Epub 2011 May 11.
7
Role of Toll-like receptors in health and diseases of gastrointestinal tract.Toll样受体在胃肠道健康与疾病中的作用。
World J Gastroenterol. 2006 Apr 14;12(14):2149-60. doi: 10.3748/wjg.v12.i14.2149.
8
Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D.幽门螺杆菌脂多糖的变异以逃避天然免疫成分表面活性蛋白D。
Infect Immun. 2005 Nov;73(11):7677-86. doi: 10.1128/IAI.73.11.7677-7686.2005.
9
Cloning and sequencing of cagA gene fragment of Helicobacter pylori with coccoid form.幽门螺杆菌球形体cagA基因片段的克隆与测序
World J Gastroenterol. 2004 Dec 1;10(23):3511-3. doi: 10.3748/wjg.v10.i23.3511.
10
Helicobacter pylori L-form and patients with chronic gastritis.幽门螺杆菌L型与慢性胃炎患者。
World J Gastroenterol. 2004 May 1;10(9):1306-9. doi: 10.3748/wjg.v10.i9.1306.